Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Apr 7, 2025
- Accession no.
- 0001562180-25-003030
- Filed
- Apr 7, 2025
- Trade date
- Apr 3, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.37M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2025 | Common Stock | MOption exerciseAcquired | +11,000 | $117.76 | +$1,295,360 | 47,781 | Direct | |
| Apr 3, 2025 | Common Stock | SSaleDisposed | −200 | $298.00 | −$59,600 | 47,581 | Direct | |
| Apr 3, 2025 | Common Stock | SSaleDisposed | −200 | $300.42 | −$60,084 | 47,381 | Direct | |
| Apr 3, 2025 | Common Stock | SSaleDisposed | −3,094 | $305.08F2 | −$943,917.52 | 44,287 | Direct | |
| Apr 3, 2025 | Common Stock | SSaleDisposed | −2,218 | $306.08F3 | −$678,885.44 | 42,069 | Direct | |
| Apr 3, 2025 | Common Stock | SSaleDisposed | −3,787 | $307.12F4 | −$1,163,063.44 | 38,282 | Direct | |
| Apr 3, 2025 | Common Stock | SSaleDisposed | −1,501 | $308.08F5 | −$462,428.08 | 36,781 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2025 | Common Stock | MOption exerciseDisposed | −11,000 | $0.00 | $0 | 37,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $304.64 to $305.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $305.64 to $306.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $306.67 to $307.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $307.685 to $308.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.